Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies

Overview of attention for article published in Cancer Management and Research, September 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 2,018)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 4 news outlets
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,923 followers.

Asunercept as an innovative therapeutic approach for recurrent gliobla | CMAR @DovePress https://t.co/p9r400olSw

13 Sep 2019

Reply Repost Favourite

Publication in Cancer Management and Research Underlines the Potential of Apogenix’ Asunercept for the Treatment of Other Malignancies Beyond Glioblastoma and MDS https://t.co/YFV4GJNVE5

04 Sep 2019